October 2009

October 2009 Supplement

Articles

EDITOR'S PAGE

BUSINESS OF RETINA

RETINA SURGERY

COVER STORIES

RETINA SURGERY

BUSINESS

DEPARTMENTS

  • INNOVATIONS

  • 5Q With David M. Brown, MD

    David M. Brown, MD, is the director of the Greater Houston Retina Research Center and practices at Retina Consultants of Houston and The Methodist Hospital in Houston, TX.

    By David M. Brown, MD

View All News >
News
BRAVO and CRUISE Show Sustained Improvement in Vision at 6 Months

Both the 0.3 mg and 0.5 mg doses of ranibizumab (Lucentis, Genentech, Inc.) clinically and statistically improved vision in branch and central retinal vein occlusions (BRVO and CRVO) according to results of the Genentech-sponsored... more >

News
Steroid Injections May Improve Vision in Some Patients With RVO

Injecting triamcinolone intravitreally appears effective in improving vision in some patients with retinal vein occlusion (RVO), according to results of the SCORE (Standard Care versus Corticosteroid for Retinal Vein Occlusion) St... more >

News
Early Treatment With Ozurdex Showed Visual Improvements

A sustained-release intravitreal 0.7-mg dexamethasone implant (Ozurdex, Allergan, Inc.) was well-tolerated and significantly improved vision in patients treated early compared with sham, according to data from identical multicente... more >

News
Bevacizumab Shown to be a Viable Treatment for DME

Intravitreal bevacizumab (Avastin; Genentech, Inc.) significantly improved vision in patients with diabetic macular edema (DME) compared with macular laser therapy, said Philip G. Hykin, MD, during his presentation at the Retina C... more >

advertisement

TOP 5 ARTICLES FROM OCTOBER 2009